Med-Metrix Acquires Armco Partners, Enhancing The Company's End-To-End Revenue Cycle Management Software And Service Capabilities

Fremont, CA: Med-Metrix, a leading provider of technology-enabled Revenue Cycle Management (RCM) solutions and a subsidiary of A&M Capital Partners ("AMCP"), has acquired ARMCO Partners. ARMCO is a prominent provider of high-quality coding and forensic medical billing services to many healthcare providers. With the acquisition of ARMCO, Med-end-to-end Metrix has expanded its portfolio of RCM software and service capabilities. Financial details of the transaction were not disclosed.

ARMCO will continue to serve more than 100 health systems at more than 500 locations, including hospitals, emergency rooms, physician practices, ambulatory care centers, clinics, and outpatient surgical centers. The Med-Metrix acquisition also synergy ARMCO's growth while preserving ARMCO's high-quality standards. ARMCO is a company established in Atlanta, Georgia, with operations in Manila, Philippines. It was founded in 2013.

Med-Founder Metrix and CEO Joseph Davi commented, "We're excited about joining forces with ARMCO and incorporating its premier coding and forensic accounts receivable solutions into our existing range of technology-enabled services. By combining our companies, we think that we would be better able to satisfy the growing RCM needs of our healthcare provider clients while also expanding our market presence."

"ARMCO is looking forward to collaborating with Med-Metrix. This partnership, we feel, is the next step in our objective to provide the best-in-class RCM solutions to the healthcare sector, "ARMCO's Founder and CEO, Jeff McQuillan, states.

We're excited to see Med-Metrix partner with Jeff McQuillan and the ARMCO team. Jeff's ARMCO business and the company he created are quite impressive. AMCP is looking forward to supporting Med-Metrix on its current path, which includes organic growth as well as additional M&A opportunities." AMCP Partner Rob Haisch said.

VRA Partners LLC and Sills Cummis & Gross P.C. advised Med-Metrix on the deal.